Antimicrobial Agents Practice Questions

Q: Which drug is used for prophylaxis against Haemophilus influenzae infection?

Rifampicin. **Explanation:** **Rifampicin** is the drug of choice for the prophylaxis of *Haemophilus influenzae* type b (Hib) infection. The primary goal of prophylaxis is to eliminate the nasopharyngeal carriage of the bacteria, thereby preventing the spread to susceptible individuals and reducing the risk of invasive disease (like meningitis or epiglottitis). Rifampicin is highly effective because it achieves high concentrations in respiratory secretions, effectively eradicating the carrier state. **Analysis of Options:** * **Rifampicin (Correct):** It is administered to all household contacts (if there is at least one unvaccinated child <4 years) to prevent secondary cases. The standard adult dose is 600 mg once daily for 4 days. * **Doxycycline:** While a broad-spectrum tetracycline, it is not used for Hib prophylaxis. It is more commonly used for prophylaxis in conditions like Malaria or Leptospirosis. * **Erythromycin:** This macrolide is the drug of choice for prophylaxis against *Bordetella pertussis* (Whooping cough) and *Corynebacterium diphtheriae*, but it is ineffective for eradicating the *H. influenzae* carrier state. **High-Yield Clinical Pearls for NEET-PG:** * **Meningococcal Prophylaxis:** Rifampicin is also used for prophylaxis against *Neisseria meningitidis* (Dose: 600 mg BID for 2 days). * **Mechanism of Action:** Rifampicin inhibits bacterial **DNA-dependent RNA polymerase**. * **Side Effect:** Warn patients about the **orange-red discoloration** of urine, sweat, and tears. * **Contraindication:** It is a potent **enzyme inducer** (CYP450), leading to numerous drug interactions (e.g., reducing the efficacy of oral contraceptives).

Q: Which of the following is an approved oral therapy for Leishmaniasis?

Miltefosine. **Explanation:** **Miltefosine** is the correct answer as it is currently the **only approved oral drug** for the treatment of both Visceral Leishmaniasis (Kala-azar) and Cutaneous Leishmaniasis [2]. Originally developed as an anticancer agent, it acts by inhibiting protein kinase C and phospholipase B, leading to apoptosis-like cell death in the *Leishmania* parasite [2]. Its oral bioavailability makes it a landmark therapy, especially in resource-limited settings where parenteral administration is difficult. **Analysis of Incorrect Options:** * **Sodium Stibogluconate (Option A):** A pentavalent antimonial that was the first-line treatment for decades [3]. It must be administered **intravenously or intramuscularly**. Its use has declined significantly due to widespread resistance (especially in Bihar, India) and cardiotoxicity [3]. * **Pentamidine (Option B):** An aromatic diamidine used as a second-line agent. It is administered **parenterally** [4] and is associated with significant toxicities, including insulin-dependent diabetes mellitus and hypotension. * **Amphotericin B (Option D):** A polyene antibiotic that is highly effective against Leishmania [1]. While Liposomal Amphotericin B is the current **drug of choice** for Kala-azar due to high cure rates, it must be administered via **slow intravenous infusion** [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Teratogenicity:** Miltefosine is strictly contraindicated in pregnancy [2]. Women of childbearing age must use effective contraception during and for 3-5 months after treatment. * **Drug of Choice:** Liposomal Amphotericin B (L-AmB) is the preferred treatment in India (single dose 10mg/kg) [3]. * **Post-Kala-azar Dermal Leishmaniasis (PKDL):** Miltefosine is also used in the management of PKDL, typically requiring a longer duration of therapy (12 weeks).

Q: Non-oliguric acute renal failure is caused by which of the following drugs?

Aminoglycoside. **Explanation:** **1. Why Aminoglycosides are correct:** Aminoglycosides (e.g., Gentamicin, Amikacin) are notorious for causing **dose-dependent nephrotoxicity**. They are filtered by the glomerulus and actively reabsorbed by the proximal convoluted tubule (PCT) cells, where they accumulate in lysosomes. This leads to tubular necrosis. Characteristically, this presents as **non-oliguric acute renal failure (ARF)**. In this condition, the glomerular filtration rate (GFR) drops, but the patient continues to produce a normal or even high volume of urine because the damaged tubules lose their ability to concentrate urine and reabsorb water. **2. Why the other options are incorrect:** * **Penicillin & Ampicillin:** While Penicillins can cause renal issues, they typically manifest as **Acute Interstitial Nephritis (AIN)**—an immune-mediated hypersensitivity reaction. This is characterized by fever, rash, eosinophilia, and eosinophiluria, rather than direct toxic non-oliguric tubular necrosis. * **Erythromycin:** This macrolide is primarily metabolized by the liver and excreted in bile. It is not associated with significant nephrotoxicity; its primary side effects are GI upset and cholestatic jaundice. **3. Clinical Pearls for NEET-PG:** * **Mechanism:** Aminoglycoside toxicity is due to accumulation in the renal cortex (PCT). * **Reversibility:** The damage is usually reversible if the drug is discontinued early. * **Monitoring:** Therapeutic Drug Monitoring (TDM) and monitoring serum creatinine are essential. * **Other causes of Non-oliguric ARF:** Amphotericin B, Cisplatin, and Methoxyflurane. * **Ototoxicity:** Remember that Aminoglycosides also cause irreversible ototoxicity (vestibular/cochlear damage).

Q: Which of the following is NOT true about protease inhibitors?

Saquinavir causes maximum induction of CYP3A4.. **Explanation:** The correct answer is **D**. This statement is incorrect because Protease Inhibitors (PIs) are primarily **inhibitors** of the CYP3A4 enzyme, not inducers. Among the PIs, **Ritonavir** is the most potent inhibitor of CYP3A4, a property utilized in "Ritonavir boosting" to increase the plasma concentrations of other PIs (like Lopinavir). Saquinavir, in fact, has the lowest inhibitory potential among the group and does not cause significant induction. **Analysis of other options:** * **Option A:** PIs are indeed substrates for **P-glycoprotein (P-gp)**, an efflux transporter encoded by the **MDR1 gene**. This transporter limits their absorption in the gut and penetration into the CNS, contributing to "sanctuary sites" where the virus can persist. * **Option B:** PIs undergo extensive **hepatic oxidative metabolism**, primarily via the CYP3A4 isoenzyme. This is why their bioavailability is highly variable and dependent on liver function. * **Option C:** Because PIs (especially Ritonavir) strongly inhibit CYP3A4, they significantly interfere with the metabolism of co-administered drugs (e.g., statins, benzodiazepines, and rifampin), leading to potential toxicity. **High-Yield Clinical Pearls for NEET-PG:** * **Ritonavir:** Used as a "pharmacokinetic enhancer" (booster) rather than for its own antiviral effect at low doses. * **Metabolic Side Effects:** PIs are classically associated with **Lipodystrophy** (buffalo hump), hyperlipidemia, and insulin resistance (hyperglycemia). * **Atazanavir:** Known for causing unconjugated hyperbilirubinemia (jaundice) but is preferred because it has the least impact on lipid profiles. * **Tipranavir:** Associated with a risk of intracranial hemorrhage.

Q: A young male presents with meningococcal meningitis and allergy to penicillin. Which is the most suitable drug?

Chloramphenicol. **Explanation:** The management of meningococcal meningitis in a patient with a **penicillin allergy** requires an antibiotic that achieves high cerebrospinal fluid (CSF) concentrations and covers *Neisseria meningitidis*. **Why Chloramphenicol is correct:** Chloramphenicol is highly lipid-soluble, allowing it to cross the blood-brain barrier effectively, reaching therapeutic levels in the CSF even without active inflammation. It is primarily bacteriostatic but acts **bactericidal** specifically against the three most common causes of bacterial meningitis: *N. meningitidis*, *S. pneumoniae*, and *H. influenzae*. Due to its distinct chemical structure, it does not cross-react with penicillins, making it the classic alternative for meningococcal meningitis in allergic patients. **Why the other options are incorrect:** * **Meropenem:** While it has excellent CNS penetration, it is a Carbapenem (a Beta-lactam). There is a risk of cross-reactivity in patients with severe penicillin allergies (Type I hypersensitivity). * **Ciprofloxacin:** While used for **prophylaxis** of meningococcal meningitis in close contacts, it is not the drug of choice for the treatment of active meningitis due to inferior clinical efficacy compared to standard agents. * **Teicoplanin:** This is a glycopeptide (similar to Vancomycin) that targets Gram-positive organisms (like MRSA). It has no activity against *N. meningitidis*, which is a Gram-negative diplococcus. **NEET-PG High-Yield Pearls:** * **Drug of Choice (DOC):** For Meningococcal meningitis, the DOC is **Ceftriaxone** or Penicillin G. * **Prophylaxis:** The DOC for prophylaxis of meningococcal meningitis is **Rifampicin** (Ciprofloxacin or Ceftriaxone are alternatives). * **Toxicity:** Remember Chloramphenicol is associated with **Bone Marrow Suppression** (dose-dependent) and **Aplastic Anemia** (idiosyncratic), as well as **Gray Baby Syndrome** in neonates.

Q: Which of the following drugs is known to cause neuropsychiatric side effects?

Cycloserine. **Explanation:** **Cycloserine** is a second-line antitubercular drug that acts by inhibiting D-alanyl-D-alanine synthetase and alanine racemase, thereby disrupting bacterial cell wall synthesis. It is highly lipid-soluble and readily crosses the blood-brain barrier. Its structural similarity to the amino acid D-alanine allows it to act as a partial agonist at the **NMDA (N-methyl-D-aspartate) receptors** in the CNS. This interaction leads to significant **neuropsychiatric side effects**, ranging from headache and somnolence to severe psychosis ("Cycloserine psychosis"), tremors, and convulsions. To mitigate these effects, it is often co-administered with Pyridoxine (Vitamin B6). **Analysis of Incorrect Options:** * **Ethosuximide:** An antiepileptic used for absence seizures. While it can cause drowsiness or GI upset, it is not primarily known for inducing the acute psychiatric disturbances associated with cycloserine. * **Pyrazinamide:** A first-line ATT drug primarily known for **hepatotoxicity** and **hyperuricemia** (leading to gout) due to inhibition of uric acid excretion. * **Rifampicin:** A bactericidal ATT drug known for causing **orange-colored secretions** (urine, sweat, tears) and being a potent **microsomal enzyme inducer**. **NEET-PG High-Yield Pearls:** * **Cycloserine Contraindication:** Strictly contraindicated in patients with a history of epilepsy or mental illness. * **Mnemonic:** Remember **"Psych-oserine"** to link Cycloserine with psychiatric side effects. * **Other drugs causing Psychosis:** Isoniazid (INH), Fluoroquinolones, and Corticosteroids.

Q: Methicillin-resistant Staphylococcus aureus (MRSA) does NOT respond to which of the following drug classes?

Oxacillin. **Explanation:** **1. Why Oxacillin is the Correct Answer:** The defining characteristic of **Methicillin-resistant *Staphylococcus aureus* (MRSA)** is its resistance to almost all beta-lactam antibiotics (except 5th generation cephalosporins like Ceftaroline). This resistance is mediated by the **mecA gene**, which encodes an altered **Penicillin-Binding Protein (PBP2a)**. PBP2a has a very low affinity for beta-lactams. Since **Oxacillin** is a penicillinase-resistant penicillin (the clinical surrogate for Methicillin), MRSA is inherently resistant to it. In laboratory settings, Oxacillin resistance is the standard marker used to identify MRSA. **2. Analysis of Incorrect Options:** * **Aminoglycosides (e.g., Gentamicin):** While many MRSA strains show multi-drug resistance, aminoglycosides are not fundamentally excluded by the mecA mechanism. They may still be used in combination therapies for certain staphylococcal infections. * **Lincosamides (e.g., Clindamycin):** These are often used to treat community-acquired MRSA (CA-MRSA) skin and soft tissue infections, provided the strain does not possess inducible resistance (checked via the D-test). * **Vancomycin:** This is a glycopeptide and remains the **drug of choice** for serious systemic MRSA infections. It acts by binding to the D-Ala-D-Ala terminus of the peptidoglycan precursor, a mechanism unaffected by the PBP2a mutation. **Clinical Pearls for NEET-PG:** * **Drug of Choice for MRSA:** Vancomycin. * **Oral options for CA-MRSA:** Linezolid, Clindamycin, Cotrimoxazole, or Doxycycline. * **The "Exception" Beta-lactam:** Ceftaroline (5th gen Cephalosporin) is the only beta-lactam that covers MRSA. * **D-Test:** Used to detect inducible clindamycin resistance in staphylococci. * **VRSA Mechanism:** Resistance is due to the replacement of D-Ala-D-Ala with **D-Ala-D-Lac**.

Q: Which of the following is a broad-spectrum antihelminthic?

Albendazole. **Explanation:** **Albendazole** is considered the drug of choice and a broad-spectrum antihelminthic because it is effective against a wide variety of nematodes (roundworms), cestodes (tapeworms), and even some trematodes. Its primary **mechanism of action** involves inhibiting microtubule synthesis by binding to parasite β-tubulin, which leads to glucose depletion and death of the parasite. Unlike Mebendazole, Albendazole has better systemic absorption (especially when taken with a fatty meal), allowing it to treat tissue-level infections like Neurocysticercosis and Hydatid disease. **Analysis of Incorrect Options:** * **Niclosamide (A):** It is a narrow-spectrum agent primarily used for intestinal tapeworms (Cestodes). It inhibits oxidative phosphorylation in the parasite but is ineffective against nematodes or tissue-stage infections. * **Mebendazole (C):** While also a benzimidazole, it has very poor systemic absorption. It is excellent for luminal (intestinal) nematodes like pinworm or whipworm but is less versatile than Albendazole for systemic or broad-spectrum use. * **Pyrantel Pamoate (D):** It is a depolarizing neuromuscular blocker effective only against luminal nematodes (Ascaris, Enterobius, and Hookworm). It is not effective against tapeworms or flukes. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC):** Albendazole is the DOC for **Hydatid disease** (*Echinococcus granulosus*) and **Neurocysticercosis** (*Taenia solium*). * **Absorption Tip:** Bioavailability of Albendazole increases significantly when administered with a **fatty meal**. * **Contraindication:** Most antihelminthics, including Albendazole, are generally avoided during the **first trimester of pregnancy** due to potential embryotoxicity. * **Praziquantel:** Often the DOC for most Trematodes (flukes) and Schistosomiasis.

Q: A patient with a positive tuberculin test (PPD) and a normal chest X-ray, who was treated with a 6-month course of prophylactic medication for tuberculosis exposure, subsequently developed peripheral neuropathies. Which one of the following vitamins would be considered a treatment for this neurotoxicity?

Vitamin B6. ### Explanation **Correct Option: D (Vitamin B6 / Pyridoxine)** **Medical Concept:** The patient has Latent Tuberculosis Infection (LTBI), indicated by a positive PPD and normal chest X-ray. The standard prophylactic drug for LTBI is **Isoniazid (INH)**. INH causes peripheral neuropathy through two mechanisms: 1. It inhibits the enzyme **pyridoxine phosphokinase**, preventing the conversion of Vitamin B6 to its active form, pyridoxal-5-phosphate (PLP). 2. It reacts with Vitamin B6 to form **isonicotinyl-hydrazone**, which is excreted in the urine, leading to a functional deficiency. Since PLP is essential for the synthesis of neurotransmitters (like GABA), its deficiency results in nerve damage. Supplementing with **Vitamin B6** bypasses this inhibition and reverses the toxicity. **Analysis of Incorrect Options:** * **A. Vitamin B1 (Thiamine):** Deficiency causes Beriberi (Dry/Wet) and Wernicke-Korsakoff syndrome, typically seen in chronic alcoholism, not INH therapy. * **B. Vitamin B2 (Riboflavin):** Deficiency leads to cheilosis, glossitis, and corneal neovascularization. * **C. Vitamin B3 (Niacin):** Deficiency causes Pellagra (Dermatitis, Diarrhea, Dementia). While INH can theoretically cause Pellagra by interfering with Tryptophan metabolism, the primary cause of *peripheral neuropathy* in this context is Vitamin B6 deficiency. **High-Yield Clinical Pearls for NEET-PG:** * **Prophylactic Dose:** 10–50 mg/day of Vitamin B6 is given to high-risk patients (diabetics, alcoholics, pregnant women, malnourished) starting INH to *prevent* neuropathy. * **Therapeutic Dose:** Higher doses (100–200 mg/day) are used to *treat* established neuropathy. * **Sideroblastic Anemia:** INH can also cause this because Vitamin B6 is a cofactor for ALA synthase (the rate-limiting step in heme synthesis). * **Slow Acetylators:** Patients who are "slow acetylators" of INH are at a much higher risk for this neurotoxicity.

Q: Pyridoxine should be administered when treating with which of the following drugs?

Isoniazid. **Explanation:** **Isoniazid (INH)** is the correct answer because it is a structural analogue of **Pyridoxine (Vitamin B6)**. INH interferes with the metabolism of B6 in two ways: it inhibits the enzyme *pyridoxine phosphokinase* (which converts B6 to its active form, pyridoxal phosphate) and increases the renal excretion of pyridoxine by forming isoniazid-pyridoxal hydrazones. A deficiency in pyridoxal phosphate leads to decreased synthesis of GABA (an inhibitory neurotransmitter), resulting in **peripheral neuropathy** (the most common side effect) and, in overdose, seizures. Administering prophylactic Pyridoxine (10–50 mg/day) prevents these neurological complications, especially in high-risk groups like diabetics, alcoholics, and pregnant women. **Why other options are incorrect:** * **Rifampicin:** Its primary side effects are hepatotoxicity and a harmless orange-red discoloration of body fluids (urine, sweat, tears). It does not affect B6 metabolism. * **Pyrazinamide:** Known for causing hyperuricemia (leading to gout) and hepatotoxicity. * **Streptomycin:** An aminoglycoside that causes ototoxicity (vestibular/cochlear damage) and nephrotoxicity. **High-Yield Clinical Pearls for NEET-PG:** * **INH Triad of Side Effects:** Peripheral neuropathy, Hepatotoxicity (most common), and Drug-induced Lupus (Anti-histone antibodies positive). * **Sideroblastic Anemia:** INH can also cause this because pyridoxal phosphate is a cofactor for ALA synthase, the rate-limiting enzyme in heme synthesis. * **Dose in Toxicity:** In acute INH poisoning (seizures), Pyridoxine is given intravenously in a gram-for-gram dose equal to the amount of INH ingested.

Question 1

Which drug is used for prophylaxis against Haemophilus influenzae infection?

Accepted Answer

Rifampicin

Answer

Doxycycline

Answer

Erythromycin

Answer

None of the above

Question 2

Which of the following is an approved oral therapy for Leishmaniasis?

Accepted Answer

Miltefosine

Answer

Sodium Stibogluconate

Answer

Pentamidine

Answer

Amphotericin B

Question 3

Non-oliguric acute renal failure is caused by which of the following drugs?

Accepted Answer

Aminoglycoside

Answer

Penicillin

Answer

Erythromycin

Answer

Ampicillin

Question 4

Which of the following is NOT true about protease inhibitors?

Accepted Answer

Saquinavir causes maximum induction of CYP3A4.

Answer

They act as a substrate for P-glycoprotein and their action is mediated by the MDR1 gene.

Answer

They undergo hepatic oxidative metabolism.

Answer

Protease inhibitors interfere with the metabolism of several drugs.

Question 5

A young male presents with meningococcal meningitis and allergy to penicillin. Which is the most suitable drug?

Accepted Answer

Chloramphenicol

Answer

Meropenem

Answer

Ciprofloxacin

Answer

Teicoplanin

Question 6

Which of the following drugs is known to cause neuropsychiatric side effects?

Accepted Answer

Cycloserine

Answer

Ethosuximide

Answer

Pyrazinamide

Answer

Rifampicin

Question 7

Methicillin-resistant Staphylococcus aureus (MRSA) does NOT respond to which of the following drug classes?

Accepted Answer

Oxacillin

Answer

Aminoglycosides

Answer

Lincosamides

Answer

Vancomycin

Question 8

Which of the following is a broad-spectrum antihelminthic?

Accepted Answer

Albendazole

Answer

Niclosamide

Answer

Mebendazole

Answer

Pyrantal pamoate

Question 9

A patient with a positive tuberculin test (PPD) and a normal chest X-ray, who was treated with a 6-month course of prophylactic medication for tuberculosis exposure, subsequently developed peripheral neuropathies. Which one of the following vitamins would be considered a treatment for this neurotoxicity?

Accepted Answer

Vitamin B6

Answer

Vitamin B1

Answer

Vitamin B2

Answer

Vitamin B3

Question 10

Pyridoxine should be administered when treating with which of the following drugs?

Accepted Answer

Isoniazid

Answer

Rifampicin

Answer

Pyrazinamide

Answer

Streptomycin

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?